HomeVTRS • NASDAQ
Viatris Inc
$11.62
Sep 27, 9:11:31 AM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$11.62
Year range
$8.74 - $13.62
Market cap
13.87B USD
Avg Volume
9.24M
P/E ratio
-
Dividend yield
4.13%
Primary exchange
NASDAQ
CDP Climate Change Score
B
Financials
Income Statement
Revenue
Net income
(USD)Jun 2024Y/Y change
Revenue
3.80B-3.11%
Operating expense
1.13B-3.58%
Net income
-326.40M-223.64%
Net profit margin
-8.60-227.60%
Earnings per share
0.69-7.76%
EBITDA
1.15B-7.03%
Effective tax rate
16.69%—
Total assets
Total liabilities
(USD)Jun 2024Y/Y change
Cash and short-term investments
1.02B43.27%
Total assets
45.33B-6.91%
Total liabilities
25.81B-7.33%
Total equity
19.52B—
Shares outstanding
1.19B—
Price to book
0.71—
Return on assets
1.94%—
Return on capital
2.40%—
Net change in cash
(USD)Jun 2024Y/Y change
Net income
-326.40M-223.64%
Cash from operations
379.10M-27.80%
Cash from investing
375.80M532.95%
Cash from financing
-847.90M-179.37%
Net change in cash
-97.40M-180.70%
Free cash flow
1.41B126.28%
About
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue. Wikipedia
Founded
Nov 16, 2020
Employees
33,000
Search
Clear search
Close search
Google apps
Main menu